| 发明名称 |
COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICTY |
| 摘要 |
The present invention provides compositions and methods that provide a high degree of sensitivity and a high degree of specificity for the preoperative assessment of ovarian tumors in a variety of subject's (e.g., pre- and post-menopausal women) having a variety of ovarian cancer types (e.g., clear cell/mucinous, low malignant potential, high malignant potential) and at a variety of disease states (e.g., early and late stage). |
| 申请公布号 |
US2016109455(A1) |
申请公布日期 |
2016.04.21 |
| 申请号 |
US201414890091 |
申请日期 |
2014.05.08 |
| 申请人 |
THE JOHNS HOPKINS UNIVERSITY ;VERMILLION, INC. |
发明人 |
MUNROE DONALD;CHAN DANIEL W.;ZHANG ZHEN |
| 分类号 |
G01N33/574 |
主分类号 |
G01N33/574 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A panel for pre-operatively assessing a subject's risk of having ovarian cancer, the panel consisting of markers CA125, ApoA1, Prealbumin, Transferrin, and Beta2 microglobulin or CA125, ApoA1, Transferrin, human epidimis protein 4 (HE4) and follicle-stimulating hormone (FSH). |
| 地址 |
Baltimore MD US |
